LTD Research Institute of Clinical Medicine

Tbilisi 0112

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Ulcerative Colitis

Studies at this site

• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed